Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis

Schiattarella et al. (Tue,) reported a other. Trimethylamine-N-oxide (TMAO) plasma levels demonstrate a positive, dose-dependent association with increased cardiovascular risk and mortality.

www.synapsesocial.com/papers/69f0cfebb606b7e8fdeb2f44 — DOI: https://doi.org/10.1093/eurheartj/ehx342

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors· 2016 · 473 citations
2. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk· 2016 · 1,880 citations
3. The jackknife-a review· 1974 · 1,386 citations
4. Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death· 2011 · 2,725 citations
5. Formation of methylamines from ingested choline and lecithin.